268 related articles for article (PubMed ID: 21586108)
21. Antifungal susceptibility testing results of New Zealand yeast isolates, 2001-2015: Impact of recent CLSI breakpoints and epidemiological cut-off values for Candida and other yeast species.
Morris AJ; Rogers K; McKinney WP; Roberts SA; Freeman JT
J Glob Antimicrob Resist; 2018 Sep; 14():72-77. PubMed ID: 29486358
[TBL] [Abstract][Full Text] [Related]
22. Antifungal susceptibility of 205 Candida spp. isolated primarily during invasive Candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and Etest methods.
Bourgeois N; Dehandschoewercker L; Bertout S; Bousquet PJ; Rispail P; Lachaud L
J Clin Microbiol; 2010 Jan; 48(1):154-61. PubMed ID: 19889902
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei.
Drago M; Scaltrito MM; Morace G;
Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):619-24. PubMed ID: 15258831
[TBL] [Abstract][Full Text] [Related]
24. [Fluconazole and itraconazole susceptibility testing with clinical yeast isolates and algae of the genus Prototheca by means of the Etest].
Blaschke-Hellmessen R
Mycoses; 1996; 39 Suppl 2():39-43. PubMed ID: 9198743
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of antifungal susceptibility testing with microdilution and Etest methods of Candida blood isolates.
Metin DY; Hilmioglu-Polat S; Samlioglu P; Doganay-Oflazoglu B; Inci R; Tumbay E
Mycopathologia; 2011 Sep; 172(3):187-99. PubMed ID: 21424603
[TBL] [Abstract][Full Text] [Related]
26. Susceptibility testing of Prototheca bovis isolates from cases of bovine mastitis using the CLSI reference broth microdilution method and the Sensititre YeastOne colorimetric panel.
Álvarez-Pérez S; Anega B; Díaz-de-Tuesta JA; González-Martín JV; Riesgo-Martínez M; García ME; Blanco JL
Med Mycol; 2021 Dec; 59(12):1257-1261. PubMed ID: 34643716
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.
Diekema DJ; Messer SA; Boyken LB; Hollis RJ; Kroeger J; Tendolkar S; Pfaller MA
J Clin Microbiol; 2009 Oct; 47(10):3170-7. PubMed ID: 19710283
[TBL] [Abstract][Full Text] [Related]
28. Antifungal susceptibility profile of invasive
Memon S; Farooqi J; Zafar U; Naqvi SF; Zafar A; Jabeen K
J Med Microbiol; 2021 Dec; 70(12):. PubMed ID: 34878377
[No Abstract] [Full Text] [Related]
29. Comparison of anidulafungin MICs determined by the clinical and laboratory standards institute broth microdilution method (M27-A3 document) and Etest for Candida species isolates.
Espinel-Ingroff A; Canton E; Peman J; Martín-Mazuelo E
Antimicrob Agents Chemother; 2010 Mar; 54(3):1347-50. PubMed ID: 20028814
[TBL] [Abstract][Full Text] [Related]
30. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
Dagi HT; Findik D; Senkeles C; Arslan U
Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
[TBL] [Abstract][Full Text] [Related]
31. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
32. Commercial systems for fluconazole susceptibility testing of yeasts: comparison with the broth microdilution method.
Posteraro B; Romano L; Sanguinetti M; Masucci L; Morace G; Fadda G
Diagn Microbiol Infect Dis; 2000 Sep; 38(1):29-36. PubMed ID: 11025181
[TBL] [Abstract][Full Text] [Related]
33. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
34. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
[TBL] [Abstract][Full Text] [Related]
35. Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints.
Chen YC; Kuo SF; Chen FJ; Lee CH
Mycoses; 2017 Feb; 60(2):89-95. PubMed ID: 27621210
[TBL] [Abstract][Full Text] [Related]
36. In vitro activities of voriconazole and five licensed antifungal agents against Candida dubliniensis: comparison of CLSI M27-A2, Sensititre YeastOne, disk diffusion, and Etest methods.
Salgado-Parreño FJ; Alcoba-Flórez J; Arias A; Moragues MD; Quindós G; Pontón J; Arévalo MP
Microb Drug Resist; 2006; 12(4):246-51. PubMed ID: 17227209
[TBL] [Abstract][Full Text] [Related]
37. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
[TBL] [Abstract][Full Text] [Related]
38. Rapid antifungal susceptibility determination for yeast isolates by use of Etest performed directly on blood samples from patients with fungemia.
Guinea J; Recio S; Escribano P; Torres-Narbona M; Peláez T; Sánchez-Carrillo C; Rodríguez-Créixems M; Bouza E
J Clin Microbiol; 2010 Jun; 48(6):2205-12. PubMed ID: 20392904
[TBL] [Abstract][Full Text] [Related]
39. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
[TBL] [Abstract][Full Text] [Related]
40. Comparison of susceptibility patterns using commercially available susceptibility testing methods performed on prevalent Candida spp.
Cretella D; Barber KE; King ST; Stover KR
J Med Microbiol; 2016 Dec; 65(12):1445-1451. PubMed ID: 27902377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
